Events
11th Annual Conference of Technological Platforms in Biomedical Research, March 5, 2018
Oral presentation: "Data sharing in biomedical research: practical questions". C. Diaz, 11th Annual Conference of Technological Platforms in Biomedical Research, 5 March 2018, Barcelona (Spain).
5th General Assembly Meeting ROADMAP project, April 25-26, 2018
The 5th ROADMAP General Assembly Meeting is organised for ROADMAP partners from 25-26 August at Hotel Constanza in Barcelona. Are you interested to learn more about ROADMAP and its activities? Contact us at info@roadmap-alzheimer.org
ISPOR 23rd Annual International Meeting, May 19-23, 2018
International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 23rd Annual International Meeting May 19-23, 2018 Baltimore Convention Center Baltimore, MD, USA Real-World Evidence, Digital Health, and the New Landscape for Health Decision Making. For more information on abstract submissions, including instructions, examples, and specific evaluation criteria, please visit www.ispor.org.
HTAi 2018 Meeting, June 1-5, 2018
Oral presentation: “Regulatory and HTA considerations in Alzheimer’s disease”. J. Bouvy, HTAi 2018 Meeting, 1-5 June, Vancouver (Canada).
Past presentations
  • Panel session: “The state of Alzheimer’s disease in Europe - innovation, value and challenges for HTA”. J. Bouvy, J. Georges, R. Handels, M. Knapp & C. Reed, Health Technology Assessment international (HTAi) Annual Meeting,17-21 June 2017, Rome (Italy).
  • Poster presentation: "Overcoming ethical issues in sharing real-world evidence in Alzheimer’s disease: The ROADMAP Project”. J. Krutzinna, Neuroethics Network 2017, 19-21 June 2017, Paris (France).
  • Poster presentation: “Real World Evidence for Alzheimer’s disease Outcomes”, Alzheimer's Association International Conference (AAIC), 16-20 July 2017, London (UK).
  • Oral presentation: “Actualités sur l’Aducanumab et étude ROADMAP”. Journées scientifiques de la fédération nationale des Centres Mémoire Ressources Recherche (FCMRR), 28-29 September 2017, Montpellier (France).
  • Symposium: “Engaging with patient organizations within IMI consortia to inform quality, relevance and value in Alzheimer’s research – insights from MOPEAD, EPAD and ROADMAP”. As part of Lilly symposium, Alzheimer Europe Conference, 2-4 October 2017, Berlin (Germany).
  • Poster presentation: “Challenges in Optimising Real World Evidence for Alzheimer’s Disease”. C. Reed, F. de Reydet de Vulpillieres, J. Gallacher, Clinical Trials on Alzheimer’s Disease (CTAD 2017), 1-4 November 2017, Boston, MA (USA).
  • Oral presentation: “Challenges in Optimizing Real World Evidence for Alzheimer’s Disease”. C. Reed, F. de Reydet de Vulpillieres, J. Gallacher, International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress, 4-8 November 2017, Glasgow (UK). http://www.sciencedirect.com/science/article/pii/S1098301517303716
  • Poster presentation: "A model for Alzheimer’s disease in the prevention setting". N. Hummel, et al., International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress 2017, 4-8 November 2017, Glasgow (UK).
  • Oral presentation: "The aims of the ROADMAP project". C. Reed, Alzheimer Association Academy, 5-6 December 2017, Brussels (Belgium).
  • Oral presentation: "The use of real-world data and evidence in regulatory and health technology assessments". M. Dekker, Alzheimer Association Academy, 5-6 December 2017, Brussels (Belgium).
  • Oral presentation: "Ethical issues raised by big data and real-world evidence projects". A. Turner, Alzheimer Association Academy, 5-6 December 2017, Brussels (Belgium).
  • Oral presentation: "Expert advisory involvement in ROADMAP". A. Santuccione Chadha, Closed meeting at Lausanne IV, 13 December 2017, Lausanne (Switzerland).
  • Poster presentation: “Real World Outcomes across the Alzheimer’s Disease spectrum for better care: Multi-modal data Access Platform”. O. Janssen, S. Vos, R. Handels, F. Verhey, P. J. Vissser,  Symposium: The Future of a Data-Driven Society, 25 January 2018, Maastricht (the Netherlands).
  • Oral presentation: “Real-world evidence in Alzheimer’s disease: the ROADMAP collaboration”. P. J. Visser, International Pharmaco-Economic Conference on Alzheimer's Disease (IPECAD), 15-16 February 2018, Paris (France).